Solid Tumor Malignancies Terminated Phase 1 Trials for Tretinoin (DB00755)

Also known as: Solid Tumor Malignancy

IndicationStatusPhase
DBCOND0032723 (Solid Tumor Malignancies)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00195156Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor MalignanciesTreatment